ERBB4 Gene <table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">ERBB4 Gene</th>
</tr>
<tr>
<td class="label">
Gene Symbol </td>
<td>ERBB4</td>
</tr>
<tr>
<td class="label">
Gene Name </td>
<td>Erb-B2 Receptor Tyrosine Kinase 4</td>
</tr>
<tr>
<td class="label">
Alternative Names </td>
<td>HER4, v-erb-a erythroblastic leukemia viral oncogene homolog 4</td>
</tr>
<tr>
<td class="label">
Chromosomal Location </td>
<td>2q34</td>
</tr>
<tr>
<td class="label">
NCBI Gene ID </td>
<td>2065</td>
</tr>
<tr>
<td class="label">
UniProt ID </td>
<td>Q15303</td>
</tr>
<tr>
<td class="label">
Ensembl ID </td>
<td>ENSG00000178668</td>
</tr>
<tr>
<td class="label">
Protein Family </td>
<td>EGFR/ERBB family</td>
</tr>
<tr>
<td class="label">
Molecular Weight </td>
<td>~180 kDa (full-length)</td>
</tr>
<tr>
<td class="label">
Amino Acids </td>
<td>1308</td>
</tr>
<tr>
<td class="label">Agent</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Neuregulin</td>
<td>ERBB4 agonist</td>
</tr>
<tr>
<td class="label">Anti-ERBB4 antibodies</td>
<td>Block signaling</td>
</tr>
<tr>
<td class="label">Tyrosine kinase inhibitors</td>
<td>Inhibit activity</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Enhance signaling</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als"
...
ERBB4 Gene <table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">ERBB4 Gene</th>
</tr>
<tr>
<td class="label">
Gene Symbol </td>
<td>ERBB4</td>
</tr>
<tr>
<td class="label">
Gene Name </td>
<td>Erb-B2 Receptor Tyrosine Kinase 4</td>
</tr>
<tr>
<td class="label">
Alternative Names </td>
<td>HER4, v-erb-a erythroblastic leukemia viral oncogene homolog 4</td>
</tr>
<tr>
<td class="label">
Chromosomal Location </td>
<td>2q34</td>
</tr>
<tr>
<td class="label">
NCBI Gene ID </td>
<td>2065</td>
</tr>
<tr>
<td class="label">
UniProt ID </td>
<td>Q15303</td>
</tr>
<tr>
<td class="label">
Ensembl ID </td>
<td>ENSG00000178668</td>
</tr>
<tr>
<td class="label">
Protein Family </td>
<td>EGFR/ERBB family</td>
</tr>
<tr>
<td class="label">
Molecular Weight </td>
<td>~180 kDa (full-length)</td>
</tr>
<tr>
<td class="label">
Amino Acids </td>
<td>1308</td>
</tr>
<tr>
<td class="label">Agent</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Neuregulin</td>
<td>ERBB4 agonist</td>
</tr>
<tr>
<td class="label">Anti-ERBB4 antibodies</td>
<td>Block signaling</td>
</tr>
<tr>
<td class="label">Tyrosine kinase inhibitors</td>
<td>Inhibit activity</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Enhance signaling</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/anxiety" style="color:#ef9a9a">Anxiety</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">83 edges</a></td>
</tr>
</table>
Introduction Erbb4 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview ERBB4 (Erb-B2 Receptor Tyrosine Kinase 4), also known as HER4, is a member of the epidermal growth factor receptor (EGFR/ERBB) family of receptor tyrosine kinases. ERBB4 is a crucial signaling receptor in the brain, involved in neural development, synaptic plasticity, and neuronal survival. The gene is located on chromosome 2q34 and encodes a 1308-amino acid protein. [@mei2008]
Protein Structure ERBB4 is a receptor tyrosine kinase with multiple isoforms:
Extracellular domain : Four ligand-binding subdomains (I-IV)
Transmembrane domain : Single pass helix
Intracellular tyrosine kinase domain : Catalytic activity
C-terminal tail : Multiple phosphorylation sites
ERBB4 has multiple isoforms due to alternative splicing:
Cytoplasmic isoforms : CYT-1, CYT-2 (differ in C-terminus)
Soluble isoforms : Produced by proteolytic cleavage
JMa and JMb : Extracellular splicing variants
Normal Function
Receptor Signaling ERBB4 functions as a receptor tyrosine kinase:
Binds neuregulin (NRG) ligands
Dimerizes (homodimer or heterodimer)
Autophosphorylates tyrosine residues
Activates downstream signaling cascades
Key Signaling Pathways
PI3K/AKT : Cell survival, metabolism
MAPK/ERK : Cell proliferation, differentiation
STAT : Gene transcription
PLCγ : Calcium signaling
Neuronal Functions In the brain, ERBB4:
Regulates neural development
Controls synapse formation
Mediates hippocampal plasticity
Supports neuronal survival
Modulates GABAergic signaling
Role in Neurodegeneration
Alzheimer's Disease ERBB4 in AD:
Elevated in AD brains
Links [Aβ](/proteins/amyloid-beta) toxicity to signaling
May have neuroprotective role
Neuregulin-ERBB4 signaling affected
Synaptic function modulation
Therapeutic target potential
Parkinson's Disease In PD:
Expressed in dopaminergic neurons
Neuregulin protection studies
May affect [LRRK2](/entities/lrrk2) signaling
Neurotrophic factor connections
Gene variants under investigation
Schizophrenia ERBB4 strongly associated with schizophrenia:
Genetic risk factor identified
Altered expression in schizophrenic brain
Affects synaptic function
Neuregulin-ERBB4 pathway dysregulated
GABAergic interneuron development
Therapeutic target interest
Other Disorders
Epilepsy : Altered expression
Autism : Genetic associations
Bipolar disorder : GWAS signals
Therapeutic Implications
Drug Targets
Therapeutic Strategies
Neuregulin delivery
ERBB4 modulation
Downstream pathway targeting
Combination approaches
Gene Expression
High in : Brain ([cortex](/brain-regions/cortex), hippocampus), heart, mammary gland
Development : Important in neurodevelopment
Adult : Maintained in specific brain regions
Cell types : [Neurons](/entities/neurons), [astrocytes](/entities/astrocytes), oligodendrocytes
Animal Models
Knockout mice : Embryonic/neonatal lethal
Conditional knockouts : Brain-specific studies
Transgenic overexpression : Neurological phenotypes
Neuregulin mutants : Synaptic deficits
Research Directions
Understanding isoform-specific functions
Brain-penetrant modulators
Biomarker development
Gene therapy approaches
Neuregulin-ERBB4 pathway modulation
Background The study of Erbb4 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
ERBB4 Protein - Protein product
EGFR/ERBB Family - Receptor family
Neuregulin - ERBB4 ligand
[Alzheimer's Disease](/diseases/al- [Parkinson's Disease](/diseases/parkinsons-disease) in AD
[Parkinson's Disease](/diseases/parkinsons-disease) Neurotrophic factors
Schizophrenia - Genetic association
External Links
[NCBI Gene: ERBB4](https://www.ncbi.nlm.nih.gov/gene/2065)
[UniProt: Q15303](https://www.uniprot.org/uniprot/Q15303)
[GeneCards: ERBB4](https://www.genecards.org/cgi-bin/carddisp.pl?gene=ERBB4)
[Human Protein Atlas: ERBB4](https://www.proteinatlas.org/gene/ERBB4)
References
Yarden Y, Sliwkowski MX, (2001) (2001)
Mei L, Xiong WC, (2008) (2008)
Law AJ, et al, (2007) (2007)
Chan CB, Ye K, (2012) (2012)
Hahn CG, et al, (2006) (2006)
Cooper MA, Koleske AJ, (2014) (2014)
Pathway Diagram The following diagram shows the key molecular relationships involving ERBB4 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Show full description